Labopharm - Product Overview

By: Labopharm  05/12/2011

Labopharm - Product Overview

Product Overview

Weare an emerging leader in optimizing the performance of existing small moleculedrugs using our proprietary controlled-release technologies. Our commercializedproducts include OLEPTRO™, a once-daily antidepressant marketed in the U.S. andapproved in Canada, and a unique once-daily formulation of tramadol marketed in19 countries, including the U.S. Our third product, a twice-daily formulationof tramadol-acetaminophen, is approved in multiple countries in Europe with launches anticipated in late 2011. We alsohave a pipeline of follow-on products in both pre-clinical and clinicaldevelopment.